Coeptis' opportunities expand with licensing deal for Pitt technology

The end of 2022 and into 2023 will be huge for the company for other reasons.

Source: bizjournals.com Health Care:Biotechnology headlines - September 30, 2022 Category: Biotechnology Authors: Paul J. Gough Source Type: news